Icon

APTIVUS (nda021814)- (250MG)

TIPRANAVIR BOEHRINGER INGELHEIM
250MG
No No
2020-Apr-29 Expired
None None
None No
APTIVUS, a protease inhibitor, co-administered with ritonavir, is indicated for combination antiretroviral treatment of HIV-1 infected patients who are treatment-experienced and infected with HIV-1 strains resistant to more than one protease inhibitor • Do not use APTIVUS/ritonavir in treatment-naïve patients
0 0 0
Total Other Developers None
Drugs with Suitability No
250MG ** ** Up - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.